HAG
BDSI

HighPoint Advisor Group’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

HighPoint Advisor Group’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$316K Sell
87,626
-8,941
-9% -$33.7K 0.03% 391
2021
Q2 		$346K Sell
96,567
-9,177
-9% -$32.4K 0.03% 373
2021
Q1 		$375K Buy
105,744
+26,145
+33% +$108K 0.04% 327
2020
Q4 		$341K Buy
+79,599
New +$307K 0.04% 326
2018
Q1 		– Sell
-9,581
Closed -$317K – 334
2017
Q4 		$317K Sell
9,581
-1,719
-15% -$4.75K 0.09% 209
2017
Q3 		$359K Buy
+11,300
New +$34.4K 0.11% 191

Other funds holding BDSI

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

HighPoint Advisor Group's BDSI Position: Q3 2021 in Review

HighPoint Advisor Group reduced its BioDelivery Sciences International, Inc. (BDSI) stake by 9.3% in Q3 2021, selling an estimated $33.7K and leaving 87,626 shares worth $316K. The position accounts for 0.03% of the portfolio, ranked #391.

HighPoint Advisor Group first reported a position in BDSI in Q3 2017 and has held it in 6 quarters since. The position peaked at $375K in Q1 2021. 151 funds tracked by Wall St. Rank hold BDSI as of Q3 2021.

  • HighPoint Advisor Group held 87,626 shares of BioDelivery Sciences International, Inc. worth $316K as of Q3 2021.
  • HighPoint Advisor Group sold 8,941 BioDelivery Sciences International, Inc. shares in Q3 2021, an estimated $33.7K.
  • BioDelivery Sciences International, Inc. made up 0.03% of HighPoint Advisor Group's portfolio in Q3 2021, its #391 holding.
  • HighPoint Advisor Group first reported a position in BioDelivery Sciences International, Inc. in Q3 2017 and has held it in 6 quarters since.
  • HighPoint Advisor Group's BioDelivery Sciences International, Inc. position peaked at $375K in Q1 2021.
  • 151 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q3 2021.

Based on HighPoint Advisor Group's 13F filing for Q3 2021, filed 15 Nov 2021.